http://venturebeat.disqus.com/News about Tech, Business and InnovationenThu, 01 Nov 2007 00:03:36 -0000http://venturebeat.com/2007/10/30/genentech-takes-a-step-back-from-the-dark-side-delays-avastin-restrictions/#comment-14680221<p>Thanks, David. I noted your subsequent item at the end of <a href="http://venturebeat.com/2007/10/31/bioroundup-clinical-trial-loopholes-newborn-screening-issues-personalized-stem-cells-and-more/" rel="nofollow noopener" target="_blank" title="http://venturebeat.com/2007/10/31/bioroundup-clinical-trial-loopholes-newborn-screening-issues-personalized-stem-cells-and-more/">this roundup</a>. We'll keep an eye on this.</p>David HamiltonThu, 01 Nov 2007 00:03:36 -0000http://venturebeat.com/2007/10/30/genentech-takes-a-step-back-from-the-dark-side-delays-avastin-restrictions/#comment-14680220<p>Stay tuned, as I am planning to get to the bottom of this one.</p><p>I'm also a little more optimistic than you are about getting the FDA to comment. I've posted an email the FDA sent the American Academy of Ophthalmology, and have followed up with the FDA in the hopes of getting more information.</p>David E. Williams of the HealtWed, 31 Oct 2007 23:00:27 -0000